《大行報告》麥格理降金沙中國(01928.HK)目標價至34.4元 下調盈測
麥格理發表報告指,金沙中國去年第四季經調整EBITDA遜該行預期7%,加上倫敦人翻新工程影響業務,該行下調對金沙中國今明兩年收入及經調整EBITDA預測,並下調對該股今明兩年淨利潤預測14.9%及8.9%,目標價由38.1元降至34.4元,維持「跑贏大市」評級。
該行引述管理層指,倫敦人第二階段翻新工程正在進行,並預計2025年首季完成。就營運而言,預計今年上半年仍然正常,因部分翻新仍等待批准,但今年下半年將見到影響。金沙中國預期倫敦人翻新後盈利能力追上威尼斯人,管理層亦提及可能為巴黎人升級,以強化其零售表現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.